Literature DB >> 19941828

Bak activation for apoptosis involves oligomerization of dimers via their alpha6 helices.

Grant Dewson1, Tobias Kratina, Peter Czabotar, Catherine L Day, Jerry M Adams, Ruth M Kluck.   

Abstract

A pivotal step toward apoptosis is oligomerization of the Bcl-2 relative Bak. We recently reported that its oligomerization initiates by insertion of an exposed BH3 domain into the groove of another Bak monomer. We now report that the resulting BH3:groove dimers can be converted to the larger oligomers that permeabilize mitochondria by an interface between alpha6 helices. Cysteine residues placed in alpha6 could be crosslinked only after apoptotic signaling. Cysteines placed at both interfaces established that the BH3:groove dimer is symmetric and that the alpha6:alpha6 interface can link these dimers into homo-oligomers containing at least 18 Bak molecules. A putative zinc-binding site in alpha6 was not required to form the alpha6:alpha6 interface, and its mutation in full-length Bak did not affect Bak conformation, oligomerization, or function. We conclude that alpha6:alpha6 interaction occurs during Bak oligomerization and proapoptotic function, but we find no evidence that zinc binding to that interface regulates apoptosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19941828     DOI: 10.1016/j.molcel.2009.11.008

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  103 in total

1.  Bax dimerizes via a symmetric BH3:groove interface during apoptosis.

Authors:  G Dewson; S Ma; P Frederick; C Hockings; I Tan; T Kratina; R M Kluck
Journal:  Cell Death Differ       Date:  2011-10-21       Impact factor: 15.828

2.  Bax forms an oligomer via separate, yet interdependent, surfaces.

Authors:  Zhi Zhang; Weijia Zhu; Suzanne M Lapolla; Yiwei Miao; Yuanlong Shao; Mina Falcone; Doug Boreham; Nicole McFarlane; Jingzhen Ding; Arthur E Johnson; Xuejun C Zhang; David W Andrews; Jialing Lin
Journal:  J Biol Chem       Date:  2010-04-09       Impact factor: 5.157

3.  BH3 domains other than Bim and Bid can directly activate Bax/Bak.

Authors:  Han Du; Jacob Wolf; Blanca Schafer; Tudor Moldoveanu; Jerry E Chipuk; Tomomi Kuwana
Journal:  J Biol Chem       Date:  2010-11-01       Impact factor: 5.157

4.  Conformational changes in BAK, a pore-forming proapoptotic Bcl-2 family member, upon membrane insertion and direct evidence for the existence of BH3-BH3 contact interface in BAK homo-oligomers.

Authors:  Kyoung Joon Oh; Pawan Singh; Kyungro Lee; Kelly Foss; Shinyoub Lee; Minji Park; Steffi Lee; Sreevidya Aluvila; Matthew Park; Puja Singh; Ryung-Suk Kim; Jindrich Symersky; D Eric Walters
Journal:  J Biol Chem       Date:  2010-07-06       Impact factor: 5.157

5.  Bcl-2 and Bax interact via the BH1-3 groove-BH3 motif interface and a novel interface involving the BH4 motif.

Authors:  Jingzhen Ding; Zhi Zhang; G Jane Roberts; Mina Falcone; Yiwei Miao; Yuanlong Shao; Xuejun C Zhang; David W Andrews; Jialing Lin
Journal:  J Biol Chem       Date:  2010-06-28       Impact factor: 5.157

6.  Mutation to Bax beyond the BH3 domain disrupts interactions with pro-survival proteins and promotes apoptosis.

Authors:  Peter E Czabotar; Erinna F Lee; Geoff V Thompson; Ahmad Z Wardak; W Douglas Fairlie; Peter M Colman
Journal:  J Biol Chem       Date:  2011-01-03       Impact factor: 5.157

7.  BH3-triggered structural reorganization drives the activation of proapoptotic BAX.

Authors:  Evripidis Gavathiotis; Denis E Reyna; Marguerite L Davis; Gregory H Bird; Loren D Walensky
Journal:  Mol Cell       Date:  2010-11-12       Impact factor: 17.970

Review 8.  Cell Death Signaling.

Authors:  Douglas R Green; Fabien Llambi
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-12-01       Impact factor: 10.005

9.  Intracellular localization of the BCL-2 family member BOK and functional implications.

Authors:  N Echeverry; D Bachmann; F Ke; A Strasser; H U Simon; T Kaufmann
Journal:  Cell Death Differ       Date:  2013-02-22       Impact factor: 15.828

Review 10.  Programmed cell death in Parkinson's disease.

Authors:  Katerina Venderova; David S Park
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.